Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 101–200 of 1,008
Improving oral bioavailability of cyclic peptides by N-methylation
Räder, A. F. B., Reichart, F., Weinmüller, M., & Kessler, H. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.031 · Cited by 215
Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
Glassman, P. M., & Muzykantov, V. R. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257113 · Cited by 209
Role of transporters in drug interactions
Han, H.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1107-y · Cited by 220
In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
Gnoth, M. J., Buetehorn, U., Muenster, U., Schwarz, T., & Sandmann, S. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180240 · Cited by 216
Xu, Y., Shrestha, N., Préat, V., & Beloqui, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.006 · Cited by 214
Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 217
Self-citationAleo, M. D., Luo, Y., Swiss, R., Bonin, P. D., Potter, D. M., & Will, Y. (2014) · Hepatology · doi:10.1002/hep.27206 · Cited by 215
“Hepatobiliary transporters also appear to play a role in adverse drug reactions.(15) One transporter of interest is the canalicular adenosine triphosphate (ATP)dependent bile salt export pump (BSEP, ABCB11).”
BackgroundChu, X., Liao, M., Shen, H., Yoshida, K., Zur, A. A., Arya, V., Galetin, A., Giacomini, K. M., Hanna, I., Kusuhara, H., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1216 · Cited by 205
Self-citationAhmed Juvale, I. I., Abdul Hamid, A. A., Abd Halim, K. B., & Che Has, A. T. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09777 · Cited by 190
SLC transporters: structure, function, and drug discovery
Colas, C., Ung, P. M.-U., & Schlessinger, A. (2016) · MedChemComm · doi:10.1039/c6md00005c · Cited by 202
Maeda, K., Ikeda, Y., Fujita, T., Yoshida, K., Azuma, Y., Haruyama, Y., Yamane, N., Kumagai, Y., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.142 · Cited by 211
Self-citationIto, S., Kusuhara, H., Yokochi, M., Toyoshima, J., Inoue, K., Yuasa, H., & Sugiyama, Y. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184986 · Cited by 211
Self-citationDahan, A., Beig, A., Lindley, D., & Miller, J. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.018 · Cited by 200
Structural and conformational determinants of macrocycle cell permeability
Over, B., Matsson, P., Tyrchan, C., Artursson, P., Doak, B. C., Foley, M. A., Hilgendorf, C., Johnston, S. E., Lee, M. D., Lewis, R. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2203 · Cited by 209
Renal drug transporters and their significance in drug–drug interactions
Yin, J., & Wang, J. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.013 · Cited by 195
Cell-Culture Models of the Blood–Brain Barrier
He, Y., Yao, Y., Tsirka, S. E., & Cao, Y. (2014) · Stroke · doi:10.1161/strokeaha.114.005427 · Cited by 194
The utility of modeling and simulation in drug development and regulatory review
Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23570 · Cited by 206
Self-citationAutophagy and doxorubicin resistance in cancer
Chen, C., Lu, L., Yan, S., Yi, H., Yao, H., Wu, D., He, G., Tao, X., & Deng, X. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000572 · Cited by 202
Tzvetkov, M. V., dos Santos Pereira, J. N., Meineke, I., Saadatmand, A. R., Stingl, J. C., & Brockmöller, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.019 · Cited by 206
Kalvass, J. C., Polli, J. W., Bourdet, D. L., Feng, B., Huang, S.-M., Liu, X., Smith, Q. R., Zhang, L. K., & Zamek-Gliszczynski, M. J. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.34 · Cited by 197
Self-citationTornio, A., Filppula, A. M., Niemi, M., & Backman, J. T. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1435 · Cited by 198
Self-citationAchar, A., Myers, R., & Ghosh, C. (2021) · Biomedicines · doi:10.3390/biomedicines9121834 · Cited by 189
Zamek-Gliszczynski, M. J., Lee, C. A., Poirier, A., Bentz, J., Chu, X., Ellens, H., Ishikawa, T., Jamei, M., Kalvass, J. C., Nagar, S., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.45 · Cited by 195
Self-citationInteractions of Green Tea Catechins with Organic Anion-Transporting Polypeptides
Roth, M., Timmermann, B. N., & Hagenbuch, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036640 · Cited by 201
Jang, S. C., Crescitelli, R., Cvjetkovic, A., Belgrano, V., Bagge, R. O., Sundfeldt, K., Ochiya, T., Kalluri, R., & Lötvall, J. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1635420 · Cited by 197
Cecchini, C., Pannilunghi, S., Tardy, S., & Scapozza, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.672267 · Cited by 193
Linville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
Minematsu, T., & Giacomini, K. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0731 · Cited by 196
Self-citationPrasad, B., Evers, R., Gupta, A., Hop, C. E. C. A., Salphati, L., Shukla, S., Ambudkar, S. V., & Unadkat, J. D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053819 · Cited by 195
Self-citationRen, X., Pan, X., Zhang, Z., Wang, D., Lu, X., Li, Y., Wen, D., Long, H., Luo, J., Feng, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301581y · Cited by 181
Mass Spectrometry Imaging in Drug Development
Nilsson, A., Goodwin, R. J. A., Shariatgorji, M., Vallianatou, T., Webborn, P. J. H., & Andrén, P. E. (2015) · Analytical Chemistry · doi:10.1021/ac504734s · Cited by 191
Wang, L., Prasad, B., Salphati, L., Chu, X., Gupta, A., Hop, C. E. C. A., Evers, R., & Unadkat, J. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061580 · Cited by 194
Self-citationRegulation of multidrug resistance by microRNAs in anti-cancer therapy
An, X., Sarmiento, C., Tan, T., & Zhu, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.002 · Cited by 194
DeGorter, M. K., Tirona, R. G., Schwarz, U. I., Choi, Y.-H., Dresser, G. K., Suskin, N., Myers, K., Zou, G., Iwuchukwu, O., Wei, W.-Q., et al. (2013) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000099 · Cited by 195
Self-citationOrganic Anion-Transporting Polypeptides
(2014) · Current Topics in Membranes · doi:10.1016/b978-0-12-800223-0.00005-0 · Cited by 187
Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
Spreckelmeyer, S., Orvig, C., & Casini, A. (2014) · Molecules · doi:10.3390/molecules191015584 · Cited by 185
Liu, J., Duan, W., Song, J., Guo, X., Wang, Z., Shi, X., Liang, J., Wang, J., Cheng, P., Chen, Y., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b05155 · Cited by 191
Brouwer, K., Aleksunes, L., Brandys, B., Giacoia, G., Knipp, G., Lukacova, V, Meibohm, B., Nigam, S., Rieder, M., de Wildt, S., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.176 · Cited by 184
Self-citationP-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
Feldmann, M., Asselin, M.-C., Liu, J., Wang, S., McMahon, A., Anton-Rodriguez, J., Walker, M., Symms, M., Brown, G., Hinz, R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70109-1 · Cited by 181
Kell, D. B., Dobson, P. D., & Oliver, S. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.010 · Cited by 186
Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues
Schiffman, S. S., & Rother, K. I. (2013) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2013.842523 · Cited by 180
Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein
Szewczyk, P., Tao, H., McGrath, A. P., Villaluz, M., Rees, S. D., Lee, S. C., Doshi, R., Urbatsch, I. L., Zhang, Q., & Chang, G. (2015) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004715000978 · Cited by 180
Functionalized liposomes for targeted breast cancer drug delivery
Nel, J., Elkhoury, K., Velot, É., Bianchi, A., Acherar, S., Francius, G., Tamayol, A., Grandemange, S., & Arab-Tehrany, E. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.12.027 · Cited by 182
Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects
Cherniakov, I., Domb, A. J., & Hoffman, A. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.999038 · Cited by 180
Novel delivery approaches for cancer therapeutics
Mitra, A. K., Agrahari, V., Mandal, A., Cholkar, K., Natarajan, C., Shah, S., Joseph, M., Trinh, H. M., Vaishya, R., Yang, X., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.067 · Cited by 183
Wiśniewski, J. R., Vildhede, A., Norén, A., & Artursson, P. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.01.016 · Cited by 185
Thwaites, D. T., & Anderson, C. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01438.x · Cited by 180
Rodríguez‐Fragoso, L., Martínez‐Arismendi, J. L., Orozco‐Bustos, D., Reyes‐Esparza, J., Torres, E., & Burchiel, S. W. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2011.02155.x · Cited by 179
Lai, Y., Chu, X., Di, L., Gao, W., Guo, Y., Liu, X., Lu, C., Mao, J., Shen, H., Tang, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.009 · Cited by 168
Self-citationCallegari, E., Malhotra, B., Bungay, P. J., Webster, R., Fenner, K. S., Kempshall, S., LaPerle, J. L., Michel, M. C., & Kay, G. G. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03961.x · Cited by 179
Pulmonary Drug Metabolism, Clearance, and Absorption
Olsson, B., Bondesson, E., Borgström, L., Edsbäcker, S., Eirefelt, S., Ekelund, K., Gustavsson, L., & Hegelund-Myrbäck, T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_2 · Cited by 183
Chowdhury, P. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803968 · Cited by 163
Drug‐Induced Liver Injury: The Role of Drug Metabolism and Transport
Corsini, A., & Bortolini, M. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.23 · Cited by 173
Transporter-Mediated Drug–Drug Interactions
Müller, F., & Fromm, M. F. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.44 · Cited by 172
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., Huber, K. V. M., Gridling, M., Chen, D., Klampfl, T., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1590 · Cited by 175
Kell, D. B., & Goodacre, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.014 · Cited by 169
The UCSF-FDA TransPortal: A Public Drug Transporter Database
Morrissey, K. M., Wen, C. C., Johns, S. J., Zhang, L., Huang, S.-M., & Giacomini, K. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.44 · Cited by 169
Self-citationKido, Y., Matsson, P., & Giacomini, K. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001629 · Cited by 169
Self-citationCardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Di Palo, K. E., Okwuosa, T. M., Przespolewski, E. R., Dent, S., & on behalf of the American Heart Association Clinical Pharmacology Committee and Cardio-Oncology Committee of the Council on Clinical Cardiology and Council on Genomic and Precision Medicine; and the Council on Peripheral Vascular Disease (2022) · Circulation · doi:10.1161/cir.0000000000001056 · Cited by 150
The Kidney and Uremic Toxin Removal: Glomerulus or Tubule?
Masereeuw, R., Mutsaers, H. A. M., Toyohara, T., Abe, T., Jhawar, S., Sweet, D. H., & Lowenstein, J. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.02.010 · Cited by 166
Jamei, M., Bajot, F., Neuhoff, S., Barter, Z., Yang, J., Rostami-Hodjegan, A., & Rowland-Yeo, K. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0097-y · Cited by 163
A clinician's guide to statin drug-drug interactions
Kellick, K. A., Bottorff, M., & Toth, P. P. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.010 · Cited by 164
International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
Giacomini, K. M., Balimane, P. V., Cho, S. K., Eadon, M., Edeki, T., Hillgren, K. M., Huang, S.-M., Sugiyama, Y., Weitz, D., Wen, Y., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.12 · Cited by 165
Self-citationSaraswathy, M., & Gong, S. (2014) · Materials Today · doi:10.1016/j.mattod.2014.05.002 · Cited by 163
Yu, K., Chen, F., & Li, C. (2012) · Current Drug Metabolism · doi:10.2174/1389200211209050577 · Cited by 163
An overview of the effective combination therapies for the treatment of breast cancer
Núñez, C., Capelo, J. L., Igrejas, G., Alfonso, A., Botana, L. M., & Lodeiro, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.027 · Cited by 162
Huo, X., Wang, C., Yu, Z., Peng, Y., Wang, S., Feng, S., Zhang, S., Tian, X., Sun, C., Liu, K., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12390 · Cited by 154
Orally Active Peptides: Is There a Magic Bullet?
Räder, A. F. B., Weinmüller, M., Reichart, F., Schumacher‐Klinger, A., Merzbach, S., Gilon, C., Hoffman, A., & Kessler, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807298 · Cited by 161
Zhao, Q. S., Luan, X., Zheng, M., Tian, X.-H., Zhao, J., Zhang, W., & Ma, B. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020128 · Cited by 178
Larregieu, C. A., & Benet, L. Z. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9456-8 · Cited by 158
Self-citationDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Di, L., Keefer, C. E., Scott, D. O., Strelevitz, T. J., Chang, G., Bi, Y., Lai, Y., Duckworth, J., Fenner, K. S., Troutman, M. D., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.043 · Cited by 174
Emerging Methods and Design Principles for Cell‐Penetrant Peptides
Peraro, L., & Kritzer, J. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801361 · Cited by 165
Yang, M., Xie, W., Mostaghel, E., Nakabayashi, M., Werner, L., Sun, T., Pomerantz, M., Freedman, M., Ross, R., Regan, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.2405 · Cited by 159
Frost, C. E., Byon, W., Song, Y., Wang, J., Schuster, A. E., Boyd, R. A., Zhang, D., Yu, Z., Dias, C., Shenker, A., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12541 · Cited by 160
Saravanakumar, A., Sadighi, A., Ryu, R. J., & Akhlaghi, F. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00750-8 · Cited by 165
Kell, D. B., & Oliver, S. G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00231 · Cited by 156
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
Toyoda, Y., Takada, T., & Suzuki, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00208 · Cited by 163
Microbial Efflux Pump Inhibition: Tactics and Strategies
Tegos, G. P., Haynes, M. K., Strouse, J. J., Khan, M. M. T., Bologa, C., Oprea, T. I., & Sklar, L. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703726 · Cited by 158
Chmiel, T., Mieszkowska, A., Kempińska-Kupczyk, D., Kot‐Wasik, A., Namieśnik, J., & Mazerska, Z. (2019) · Microchemical Journal · doi:10.1016/j.microc.2019.01.030 · Cited by 167
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Ashique, S., Bhowmick, M., Pal, R., Khatoon, H., Kumar, P., Sharma, H., Garg, A., Kumar, S., & Das, U. (2024) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2024.100114 · Cited by 139
Genovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
Anwer, M. S., & Stieger, B. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1367-0 · Cited by 148
Yoshida, K., Maeda, K., & Sugiyama, Y. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.351 · Cited by 155
Self-citationTransporters in Drug Development and Clinical Pharmacology
Giacomini, K. M., & Sm, H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.86 · Cited by 156
Self-citationEvaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
Jouan, E., Vée, M. L., Mayati, A., Denizot, C., Parmentier, Y., & Fardel, O. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020012 · Cited by 156
Kidney-based in vitro models for drug-induced toxicity testing
Faria, J., Ahmed, S., Gerritsen, K. G. F., Mihaila, S. M., & Masereeuw, R. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02598-0 · Cited by 168
Döring, B., & Petzinger, E. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882353 · Cited by 135
Kusuhara, H., Furuie, H., Inano, A., Sunagawa, A., Yamada, S., Wu, C., Fukizawa, S., Morimoto, N., Ieiri, I., Morishita, M., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01887.x · Cited by 159
Self-citationBentz, J., O’Connor, M. P., Bednarczyk, D., Coleman, J., Lee, C., Palm, J. E., Pak, Y. A., Perloff, E. S., Reyner, E. L., Balimane, P. V., et al. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050500 · Cited by 165
Self-citationPrasad, B., Johnson, K., Billington, S. F., Lee, C. G. L., Chung, G., Brown, C., Kelly, E. J., Himmelfarb, J., & Unadkat, J. D. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072066 · Cited by 151
Self-citationYee, S. W., Brackman, D. J., Ennis, E. A., Sugiyama, Y., Kamdem, L. K., Blanchard, R. L., Galetin, A., Zhang, L., & Giacomini, K. M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1098 · Cited by 155
Self-citationThe Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review
Huang, S.-M., & Rowland, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.320 · Cited by 150
Taskar, K. S., Reddy, V. P., Burt, H. J., Posada, M. M., Varma, M. V. S., Zheng, M., Ullah, M., Riedmaier, A. E., Umehara, K., Snoeys, J., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1693 · Cited by 156
Self-citationSchaeffeler, E., Hellerbrand, C., Nies, A. T., Winter, S., Kruck, S., Hofmann, U., van der Kuip, H., Zanger, U. M., Koepsell, H., & Schwab, M. G. (2011) · Genome Medicine · doi:10.1186/gm298 · Cited by 157
Nassif, A., Jia, J., Keiser, M., Oswald, S., Modeß, C., Nagel, S., Weitschies, W., Hosten, N., Siegmund, W., & Kühn, J. (2012) · Radiology · doi:10.1148/radiol.12112061 · Cited by 149
Wang, L., & Sweet, D. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9413-y · Cited by 150
Miyata, H., Takada, T., Toyoda, Y., Matsuo, H., Ichida, K., & Suzuki, H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00518 · Cited by 158
Gertz, M., Cartwright, C. M., Hobbs, M. J., Kenworthy, K. E., Rowland, M., Houston, J. B., & Galetin, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0918-y · Cited by 154
Prueksaritanont, T., Tatosian, D., Chu, X., Railkar, R. A., Evers, R., Chavez-Eng, C. M., Lutz, R., Zeng, W., Yabut, J. A., Chan, G., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.525 · Cited by 148
Self-citation
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.